Reducing carbon dioxide (CO2) emissions
Reducing carbon dioxide (CO2) emissions
CO2 is recognized as a leading cause of global warming.
As a responsible company addressing climate change, Taisho Pharmaceutical Group is committed to reducing CO2 emissions.
CO2 is recognized as a leading cause of global warming.
As a responsible company addressing climate change, Taisho Pharmaceutical Group is committed to reducing CO2 emissions.
Group-wide target for reduction of carbon dioxide (CO2) emissions
Group-wide target for reduction of carbon dioxide (CO2) emissions
To achieve the national goal of carbon neutrality by 2050, we aim to reduce CO2 emissions (Scope 1 and 2*1) by 46% in fiscal year 2030 compared to fiscal year 2013.
To achieve the national goal of carbon neutrality by 2050, we aim to reduce CO2 emissions (Scope 1 and 2*1) by 46% in fiscal year 2030 compared to fiscal year 2013.
Energy saving targets at offices
Energy saving targets at offices
Endeavor to raise our energy consumption rate*2 throughout the Group and remain at A-class or higher*3 in the evaluation system by class under the Act on Rationalization of Energy Use and Shift to Non-fossil Energy
Endeavor to raise our energy consumption rate*2 throughout the Group and remain at A-class or higher*3 in the evaluation system by class under the Act on Rationalization of Energy Use and Shift to Non-fossil Energy
Refurbish the equipment to save energy and CO2
Refurbish the equipment to save energy and CO2
Approximately 60% of the CO2 emissions from Taisho Pharmaceutical are generated by our factories, where energy consumption is also concentrated. Therefore, implementing measures such as introducing the latest production equipment is crucial. We regularly update our production facilities, selecting equipment that prioritizes energy efficiency and CO2 reduction whenever possible.
For example, by converting air conditioning systems and pumps to inverter types, we prevent excessive motor rotation. Additionally, we reduce CO2 emissions by switching to high-efficiency refrigeration units, converting energy sources (from city gas to electricity), and recovering waste heat.
Approximately 60% of the CO2 emissions from Taisho Pharmaceutical are generated by our factories, where energy consumption is also concentrated. Therefore, implementing measures such as introducing the latest production equipment is crucial. We regularly update our production facilities, selecting equipment that prioritizes energy efficiency and CO2 reduction whenever possible.
For example, by converting air conditioning systems and pumps to inverter types, we prevent excessive motor rotation. Additionally, we reduce CO2 emissions by switching to high-efficiency refrigeration units, converting energy sources (from city gas to electricity), and recovering waste heat.
Inverter-like pieces of equipment
Inverter-like pieces of equipment
High-efficiency, fuel-conversion freezer
High-efficiency, fuel-conversion freezer
Additionally, a significant amount of energy is consumed when transporting products by truck. Therefore, we are working on "modal shift" initiatives to switch to transportation methods with lower energy consumption, such as ships and railways, and improving fuel efficiency.
Additionally, a significant amount of energy is consumed when transporting products by truck. Therefore, we are working on "modal shift" initiatives to switch to transportation methods with lower energy consumption, such as ships and railways, and improving fuel efficiency.
Energy saving target in product transportation
Energy saving target in product transportation
Reduce our energy consumption rate in transportation by 1% or more on an annual average by FY2025.
Reduce our energy consumption rate in transportation by 1% or more on an annual average by FY2025.
Cooperating with municipalities and industry organizations as well
Cooperating with municipalities and industry organizations as well
Saitama prefecture has an ordinance to promote anti-global warming measures, requiring local companies to reduce CO2 emissions from within the prefecture. The reduction target is shown to the right.
Saitama prefecture has an ordinance to promote anti-global warming measures, requiring local companies to reduce CO2 emissions from within the prefecture. The reduction target is shown to the right.
Target for reduction of carbon dioxide (CO2) emissions as defined by the Saitama prefecture's ordinance
Target for reduction of carbon dioxide (CO2) emissions as defined by the Saitama prefecture's ordinance
Ensure that the average CO2 emissions in the FY2022 – FY2024 period are 20% smaller than those in the FY2002 – FY2004 period.
Ensure that the average CO2 emissions in the FY2022 – FY2024 period are 20% smaller than those in the FY2002 – FY2004 period.
Omiya Factory, Hanyu Factory, and Comprehensive Research Institute are located in Saitama Prefecture. These facilities consume about 70% of the energy used by Taisho Pharmaceutical domestically and emit over 30,000 tons of CO2. These factories and research institutes are particularly focused on energy conservation and CO2 reduction to meet regulatory targets. Through initiatives such as introducing energy-efficient equipment, we are gradually reducing emissions.
Additionally, we participate in the "Carbon Neutral Action Plan" of the Japan Pharmaceutical Manufacturers Association (JPMA), an industry organization. We are working together to prevent global warming while responding to various societal demands.
Omiya Factory, Hanyu Factory, and Comprehensive Research Institute are located in Saitama Prefecture. These facilities consume about 70% of the energy used by Taisho Pharmaceutical domestically and emit over 30,000 tons of CO2. These factories and research institutes are particularly focused on energy conservation and CO2 reduction to meet regulatory targets. Through initiatives such as introducing energy-efficient equipment, we are gradually reducing emissions.
Additionally, we participate in the "Carbon Neutral Action Plan" of the Japan Pharmaceutical Manufacturers Association (JPMA), an industry organization. We are working together to prevent global warming while responding to various societal demands.
Curbing fluorocarbon emissions
Curbing fluorocarbon emissions
Although chlorofluorocarbons (CFCs), once widely used as refrigerants in air conditioners and refrigerators, are a type of greenhouse gas, our factories rarely emit CFCs directly. However, there is a risk of CFC leakage during the malfunction or replacement of old air conditioners. Therefore, we have established a comprehensive management system for equipment using CFCs across the company. We have appointed a chief management officer and designated management officers and managers at each site to systematically manage these substances.
Although chlorofluorocarbons (CFCs), once widely used as refrigerants in air conditioners and refrigerators, are a type of greenhouse gas, our factories rarely emit CFCs directly. However, there is a risk of CFC leakage during the malfunction or replacement of old air conditioners. Therefore, we have established a comprehensive management system for equipment using CFCs across the company. We have appointed a chief management officer and designated management officers and managers at each site to systematically manage these substances.
Target for curbing fluorocarbon emissions
Target for curbing fluorocarbon emissions
Comply with the law (simplified inspections, periodic inspections and reporting on calculated amount of leakage).
Educate all Taisho Pharmaceutical Group companies' fluorocarbon managers in an effort to reduce leakage.
Comply with the law (simplified inspections, periodic inspections and reporting on calculated amount of leakage).
Educate all Taisho Pharmaceutical Group companies' fluorocarbon managers in an effort to reduce leakage.
Notes and Additional Information
*1 Scopes 1 and 2: CO2 emissions are generally categorized into Scope 1, 2, and 3 based on their sources. Scope 1 refers to CO2 directly emitted from the company through activities such as fuel combustion. Scope 2 refers to CO2 indirectly emitted through the use of electricity and other energy purchased from other companies. Scope 3 encompasses CO2 emissions from the entire supply chain, excluding those covered by Scope 1 and 2.
*2 The calculation formula is as follows:
Factories and Research Facilities: Energy consumption (kL) / Number of units produced (hundreds of millions) or Production value (hundreds of millions of yen) × Total floor area (m²)
Office-based Business Locations: Energy consumption (kL) / Total floor area (m²)
*3 A-class or higher in the evaluation system by class under the Act on Rationalization of Energy Use and Shift to Non-fossil Energy: The Act classifies companies and organizations into four classes including S, A, B and C depending on the degree of achievement of energy saving. Companies in A-class are deemed as making a certain level of effort and are expected to try even more.
Notes and Additional Information
*1 Scopes 1 and 2: CO2 emissions are generally categorized into Scope 1, 2, and 3 based on their sources. Scope 1 refers to CO2 directly emitted from the company through activities such as fuel combustion. Scope 2 refers to CO2 indirectly emitted through the use of electricity and other energy purchased from other companies. Scope 3 encompasses CO2 emissions from the entire supply chain, excluding those covered by Scope 1 and 2.
*2 The calculation formula is as follows:
Factories and Research Facilities: Energy consumption (kL) / Number of units produced (hundreds of millions) or Production value (hundreds of millions of yen) × Total floor area (m²)
Office-based Business Locations: Energy consumption (kL) / Total floor area (m²)
*3 A-class or higher in the evaluation system by class under the Act on Rationalization of Energy Use and Shift to Non-fossil Energy: The Act classifies companies and organizations into four classes including S, A, B and C depending on the degree of achievement of energy saving. Companies in A-class are deemed as making a certain level of effort and are expected to try even more.
